Related Experiment Video
Updated: May 2, 2026

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
Published on: August 12, 2017
Treating the donor
Dermot W McKeown1, Jonathan Ball
1aScottish Liver Transplant Unit, Edinburgh Royal Infirmary, Edinburgh bGeneral and Neurointensive Care, St George's Hospital and Medical School, London, UK.
Optimizing care for brain-dead organ donors (DBD) is crucial for increasing organ availability. Evidence-based critical care and early identification of potential donors lead to more transplantable organs.
Area of Science:
- Critical care medicine
- Transplantation science
- Organ donation research
Background:
- Increasing organ demand necessitates maximizing organ donation potential.
- The donor population is aging with increased comorbidities.
- Optimal management of donors after brain death (DBD) is vital for transplanting more organs per donor.
Purpose of the Study:
- To review evidence-based drugs and techniques for optimizing donor management.
- To define best practices for critical care in brain-dead organ donors.
- To reassess the efficacy of previously recommended therapies.
Main Methods:
- Review of current critical care practices for brain-dead donors.
- Analysis of outcomes associated with specific supportive therapies.
- Evaluation of emerging extracorporeal support techniques.
Main Results:
- Targeted supportive therapy by experienced specialists improves donation outcomes.
- Prolonged (>24h) ex-vivo organ conditioning shows significant benefits.
- Extracorporeal support may identify new donor sources in non-responders.
Conclusions:
- Early identification of potential DBD and best practice critical care increase transplantable organs.
- Defined treatment goals are associated with better organ yield.
- International efforts are underway to address challenges in donor management research.
More Related Videos
09:54Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
Published on: August 15, 2022
08:33A Standardized Murine Model with a Three-Person Workflow for Studying Acute Cellular and Antibody-Mediated Rejection in Xenotransplantation
Published on: March 20, 2026
Related Concept Videos
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant I: Introduction
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Kidney Transplant II: Surgical Procedure